About Us Advancing medicines Solving therapeutic problems Improving lives Aquestive Therapeutics is a pharmaceutical company that advances and commercializes medicines to solve critical therapeutic problems and meaningfully improve people’s lives. We apply innovative drug delivery technology and scientific expertise to redesign important medicines. Our initial focus, supported by our current approved products and late stage pipeline, is to improve medications and outcomes for patients with central nervous system (CNS) conditions. A message from Aquestive’s CEO Over the past decade, Aquestive Therapeutics has applied its innovative drug delivery technology to become the undisputed leader in developing and delivering medications through film. Our team of scientists and innovators work to solve important therapeutic problems with redesigned medicines. Whether we are working alone, or in collaboration with industry partners, we aim to transform the treatment landscape with new medicines that deliver meaningful clinical benefit and are accessible for more people. Patient and caregiver needs are at the heart of every advance we make – in CNS and beyond. Keith J. Kendall Chief Executive Officer Patient centricity We consult with and listen to our patients. Our technologies aim to address shortfalls in medication design that make it hard for patients to use the medicines they’re prescribed. Making a meaningful difference Our therapeutic solutions make life-saving medications available to those who need them most by enhancing the way they are delivered. Meet our team We are focused problem solvers who work to empower patients and their caregivers. Our team hails from a variety of backgrounds and disciplines, and has created a collaborative culture where different viewpoints are valued and challenging the status quo is the norm. Keith J. Kendall, Chief Executive Officer, President and Director Aquestive Daniel Barber, SVP, Chief Operating Officer Peter Boyd, SVP, Business Process and Information Technology Lori J. Braender, SVP, General Counsel Mark Lepore, M.D., Chief Medical Officer, Allergy Ken Marshall, SVP, Chief Commercial Officer Mark Schobel, Chief Innovation & Technology Officer Gary H. Slatko, M.D., SVP, Chief Medical Officer, Neurology Ernie Toth, SVP, Chief Financial Officer Theresa Wood, SVP, Human Resources Board of Directors We’re fortunate to have experienced industry leaders on our active Board of Directors. Santo J. Costa, Chairman of the Board Aquestive Board Member of Cytokinetics, Inc. Keith J. Kendall, Chief Executive Officer, President and Director Aquestive Gregory B. Brown, M.D., Director Aquestive Director and Chief Executive Officer of Memgen, LLC, Co-founder and Vice Chairman at Healthcare Royalty Partners (HCR) Member of HCR’s Senior Advisor Board Board Member of Caladrius Biosciences, Inc. and Faron Pharmaceuticals, Ltd. John Cochran, Director Aquestive Partner at Bratton Capital Management L.P. Partner and Chief Operating Officer at Crestline Investors, Inc. Julie Krop, M.D., Director Aquestive Chief Medical Officer of Freeline Therapeutics Nancy S. Lurker, Director Aquestive Director, President, and Chief Executive Officer EyePoint Pharmaceuticals, Inc. James S. Scibetta, Director Aquestive Director and Chief Executive Officer of ImmuneID, Inc. Marco Taglietti, M.D., Director Aquestive Director, President, and Chief Executive Officer of SCYNEXIS Inc. Contact Us About Us Our Medicines Pipeline Innovative Drug Delivery Collaborations Investors Careers Newsroom Images of individuals were purchased by Aquestive® Therapeutics and are intended to model real patient scenarios. © 2020 Aquestive Therapeutics, Inc. PharmFilm®, Sympazan®, and the Aquestive logo are registered trademarks of Aquestive Therapeutics, Inc. All rights reserved. Terms of Use Privacy Policy Corporate Governance Code of Conduct California Compliance Declaration California Consumer Privacy Policy Sitemap This site uses cookies to store information on your computer. Some are essential to make our site work; others help us improve the user experience. By using the site, you consent to the placement of these cookies. OkLearn More